Boothbay Fund Management’s Harvard Bioscience HBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-1,151,397
| Closed | -$2.43M | – | 1377 |
|
|
2024
Q4 | $2.43M | Sell |
1,151,397
-184,423
| -14% | -$389K | 0.06% | 322 |
|
|
2024
Q3 | $3.59M | Hold |
1,335,820
| – | – | 0.08% | 273 |
|
|
2024
Q2 | $3.81M | Sell |
1,335,820
-8,488
| -0.6% | -$24.2K | 0.09% | 255 |
|
|
2024
Q1 | $5.7M | Sell |
1,344,308
-17,711
| -1% | -$75.1K | 0.11% | 156 |
|
|
2023
Q4 | $7.29M | Buy |
1,362,019
+87,500
| +7% | +$468K | 0.19% | 86 |
|
|
2023
Q3 | $5.48M | Buy |
1,274,519
+100,272
| +9% | +$431K | 0.13% | 149 |
|
|
2023
Q2 | $6.45M | Sell |
1,174,247
-60,851
| -5% | -$334K | 0.14% | 129 |
|
|
2023
Q1 | $5.19M | Buy |
1,235,098
+162,269
| +15% | +$682K | 0.11% | 198 |
|
|
2022
Q4 | $2.97M | Buy |
1,072,829
+680,117
| +173% | +$1.88M | 0.07% | 351 |
|
|
2022
Q3 | $1.01M | Buy |
392,712
+51,055
| +15% | +$131K | 0.03% | 757 |
|
|
2022
Q2 | $1.23M | Buy |
341,657
+281,657
| +469% | +$1.01M | 0.03% | 649 |
|
|
2022
Q1 | $373K | Buy |
+60,000
| New | +$373K | 0.01% | 1161 |
|